PATENT CLAIM ANALYSIS

Application Number: 16008461
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the Serpina1 gene, and methods of using such RNAi agents to inhibit expression of Serpina1 and methods of treating subjects having a Serpina1 associated disease, such as a liver disorder.

Claim (Index 13):
A composition comprising a modified antisense polynucleotide agent, wherein said agent is capable of inhibiting the expression of Serpina1 in a cell, and comprises a sequence complementary to a sense sequence selected from the group of the sequences listed in any one of Tables 1, 2, 5, 7, 8, and 9, wherein the polynucleotide is about 14 to about 30 nucleotides in length.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 94.0
- Lexical Diversity: 1.56667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15399820', '14284745', '14947025', '14976261', '14699140']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8763207030345624
- 35 USC 102 Novelty (BERT): 0.6549605838333418
- Combined Prediction Score: 0.8541846911144404
- Mean Citation Score: 683.64558
- Max Citation Score: 773.87994
- Similarity Product: 592.0432821567714

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test